Benitec Biopharma Inc. (BNTC)
NASDAQ: BNTC · IEX Real-Time Price · USD
9.47
+0.62 (7.01%)
At close: May 16, 2024, 4:00 PM
9.53
+0.06 (0.63%)
After-hours: May 16, 2024, 7:31 PM EDT
Benitec Biopharma Market Cap
Benitec Biopharma has a market cap or net worth of $86.09 million as of May 16, 2024. Its market cap has increased by 1,266.46% in one year.
Market Cap
86.09M
Enterprise Value
76.85M
1-Year Change
1,266.46%
Ranking
Category
Stock Price
$9.47
Market Cap Chart
Since August 18, 2015, Benitec Biopharma's market cap has increased from $46.20M to $86.09M, an increase of 86.34%. That is a compound annual growth rate of 7.37%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 15, 2024 | 82.90M | 4.94% |
May 14, 2024 | 79.00M | 3.81% |
May 13, 2024 | 76.10M | 217.08% |
May 10, 2024 | 24.00M | 0.84% |
May 9, 2024 | 23.80M | 6.25% |
May 8, 2024 | 22.40M | 6.16% |
May 7, 2024 | 21.10M | -2.31% |
May 6, 2024 | 21.60M | -6.90% |
May 3, 2024 | 23.20M | 0.87% |
May 2, 2024 | 23.00M | 12.20% |
May 1, 2024 | 20.50M | -6.39% |
Apr 30, 2024 | 21.90M | 13.47% |
Apr 29, 2024 | 19.30M | 7.82% |
Apr 26, 2024 | 17.90M | -0.56% |
Apr 25, 2024 | 18.00M | 3.45% |
Apr 24, 2024 | 17.40M | -2.25% |
Apr 23, 2024 | 17.80M | 2.30% |
Apr 22, 2024 | 17.40M | -3.87% |
Apr 19, 2024 | 18.10M | 2.26% |
Apr 18, 2024 | 17.70M | 42.74% |
Apr 17, 2024 | 12.40M | - |
Apr 16, 2024 | 12.40M | -2.36% |
Apr 15, 2024 | 12.70M | -11.19% |
Apr 12, 2024 | 14.30M | -11.73% |
Apr 11, 2024 | 16.20M | 4.52% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Athira Pharma | 85.12M |
Aclaris Therapeutics | 83.38M |
Gritstone bio | 81.81M |
Alpha Teknova | 80.83M |
Celularity | 80.59M |
Passage Bio | 80.21M |
BioXcel Therapeutics | 79.78M |
HOOKIPA Pharma | 79.70M |